Revision of CureVac

← Back to history

AB · · mediawikibotAB-V1

Rendered

File:Curevac in Tübingen 02.jpg CureVac N.V. is a German biopharmaceutical company that develops therapies based on messenger RNA (mRNA). Legally domiciled in the Netherlands and headquartered in Tübingen, Germany, the company was founded in 2000 by Ingmar Hoerr (CEO), Steve Pascolo (CSO), Florian von der Mulbe (COO), Günther Jung, and Hans-Georg Rammensee. from Wikipedia

VIAF: 264796105

biopharmaceutical company in Germany

Wikitext diff vs parent

{{DISPLAYTITLE:CureVac}}[[File:Curevac in Tübingen 02.jpg|frameless|right]]
CureVac N.V. is a German biopharmaceutical company that develops therapies based on messenger RNA (mRNA). Legally domiciled in the Netherlands and headquartered in Tübingen, Germany, the company was founded in 2000 by Ingmar Hoerr (CEO), Steve Pascolo (CSO), Florian von der Mulbe (COO), Günther Jung, and Hans-Georg Rammensee.<small> from [https://en.wikipedia.org/wiki/CureVac Wikipedia]</small>

{{SF|
{{Twt|CureVacAG}}
{{Wb|https://www.curevac.com/|curevac.com}}
{{Fb|CureVac}}
{{Yt|UCtwge2rdqHr50rxnf45ltcw|CureVac}}
}}
{{IDF|
{{Wd|Q1144473}}
{{Isni|0000000453454022}}
}}
{{VIAF|264796105}}

{{VHID|17465622300}}{{#subtitle: <big>biopharmaceutical company in Germany</big>}}